Douglas Tsao

Stock Analyst at HC Wainwright & Co.

(2.30)
# 2,566
Out of 4,902 analysts
506
Total ratings
38.48%
Success rate
-0.69%
Average return

Stocks Rated by Douglas Tsao

Disc Medicine
Jul 3, 2025
Reiterates: Buy
Price Target: $118
Current: $57.79
Upside: +104.19%
argenx SE
Jul 1, 2025
Reiterates: Buy
Price Target: $720
Current: $572.71
Upside: +25.72%
Crinetics Pharmaceuticals
Jun 27, 2025
Reiterates: Buy
Price Target: $81
Current: $33.02
Upside: +145.31%
Roivant Sciences
Jun 18, 2025
Reiterates: Buy
Price Target: $18
Current: $11.65
Upside: +54.57%
Sage Therapeutics
Jun 17, 2025
Reiterates: Neutral
Price Target: $12
Current: $9.14
Upside: +31.29%
Cabaletta Bio
Jun 11, 2025
Reiterates: Buy
Price Target: $25
Current: $1.68
Upside: +1,388.10%
Protagonist Therapeutics
Jun 3, 2025
Reiterates: Buy
Price Target: $80
Current: $56.44
Upside: +41.74%
Xenon Pharmaceuticals
May 13, 2025
Reiterates: Buy
Price Target: $53
Current: $32.11
Upside: +65.06%
Praxis Precision Medicines
May 1, 2025
Reiterates: Buy
Price Target: $105
Current: $54.94
Upside: +91.12%
Coherus Oncology
Apr 29, 2025
Reiterates: Buy
Price Target: $7
Current: $0.90
Upside: +681.42%
Reiterates: Buy
Price Target: $14
Current: $5.54
Upside: +152.71%
Reiterates: Buy
Price Target: $34
Current: $17.05
Upside: +99.41%
Reiterates: Buy
Price Target: $27
Current: $9.34
Upside: +189.08%
Reiterates: Buy
Price Target: $19
Current: $15.48
Upside: +22.74%
Reiterates: Buy
Price Target: $12
Current: $2.50
Upside: +380.00%
Reiterates: Buy
Price Target: $18
Current: $4.86
Upside: +270.37%
Reiterates: Buy
Price Target: $51
Current: $18.28
Upside: +178.99%
Reiterates: Buy
Price Target: $18
Current: $1.71
Upside: +952.63%
Reiterates: Buy
Price Target: $54
Current: $15.11
Upside: +257.38%
Reiterates: Buy
Price Target: $57
Current: $20.04
Upside: +184.43%
Reiterates: Buy
Price Target: $15
Current: $11.62
Upside: +29.09%
Reiterates: Neutral
Price Target: $5
Current: $1.99
Upside: +151.26%
Maintains: Buy
Price Target: $30$3
Current: $2.31
Upside: +29.87%
Reiterates: Neutral
Price Target: $46
Current: $29.36
Upside: +56.68%
Reiterates: Buy
Price Target: $8
Current: $4.25
Upside: +88.24%
Reiterates: Buy
Price Target: $360
Current: $0.78
Upside: +46,113.09%
Downgrades: Neutral
Price Target: $10
Current: $1.15
Upside: +769.57%
Maintains: Equal-Weight
Price Target: $168$182
Current: $146.88
Upside: +23.91%
Downgrades: Neutral
Price Target: $19
Current: $7.30
Upside: +156.85%
Maintains: Underweight
Price Target: $25$18
Current: $29.73
Upside: -39.46%
Initiates: Underweight
Price Target: $8
Current: $16.31
Upside: -50.95%
Initiates: Overweight
Price Target: $52
Current: $22.28
Upside: +133.39%